[Surgical therapy for Parkinson's disease].
Tomita
S
S
Department of Neurological Surgery, Okayama University Medical School, Japan.
Date
I
I
Ohmoto
T
T
D000818:Animals; D001921:Brain / Q000601:surgery; D016380:Brain Tissue Transplantation; D020934:Ciliary Neurotrophic Factor / Q000096:biosynthesis; D004599:Electric Stimulation Therapy; D016222:Fibroblast Growth Factor 2 / Q000096:biosynthesis; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D009044:Motor Cortex / Q000503:physiopathology; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D010300:Parkinson Disease / Q000503:physiopathology / Q000601:surgery*; D013788:Thalamus / Q000601:surgery
D020934:Ciliary Neurotrophic Factor; C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D016222:Fibroblast Growth Factor 2